Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells
Journal of Veterinary Internal Medicine · 2026
DOI: 10.1093/jvimsj/aalaf015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2026. Verfasst von Ewelina Semik-Gurgul und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Molecular Biology, National Research Institute of Animal Production, Krakowska 1 Street, 32-083 Balice, Poland. Hauptthemen laut MEDLINE: Cannabidiol, Skin Neoplasms, Horse Diseases. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Sarcoids are locally invasive skin tumors in equids, associated with bovine papillomavirus. Hypothesis/Objectives Address potential applications of cannabidiol (CBD) in veterinary medicine. We evaluated the response of equine sarcoid cells to CBD in vitro, focusing on viability, invasiveness, and matrix remodeling. Animals Three primary sarcoid cell lines.
Methods
Cells were treated with CBD (20, 6.75, 2.25, 0.75 μM) and incubated for 6, 24, 48, 72 hours. Cell viability, cytotoxicity, and apoptosis were assessed using the ApoTox-Glo Assay. Based on these results, further analyses were performed for selected conditions only, including the assessment of cell invasiveness using the ECMatrix™ Cell Invasion Assay and the quantification of matrix metalloproteinase (MMP)-1, -2, and -9 in the culture medium by ELISA.
Results
Treatment with CBD affected cell viability, cytotoxicity, and apoptosis. At 48 hours, apoptosis (measured as caspase 3/7 activity) reached 49.5% and further increased to 75% at 72 hours. Marked cytotoxicity (>96%) and decreased viability were observed at 72 hours. Cannabidiol also significantly decreased MMP-1 concentration by 48.9% at 24 hours and MMP-2 concentrations by 84% at 6 hours. Concentrations of MMP-9 also decreased by 37.2% and 45.3% at 6 and 48 hours, respectively, after treatment with 20 μM. Despite observed decreases in cell invasiveness ranging from 34% to 59% after 24 hours, these changes were not significant. Conclusions and clinical importance Our findings support further investigation of CBD’s role in extracellular matrix modulation in sarcoid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Animal Molecular Biology, National Research Institute of Animal Production, Krakowska 1 Street, 32-083 Balice, Poland.
- Department of Infectious Diseases and Public Health Protection, University of Agriculture in Krakow, 1C Redzina Street, 30-248 Krakow, Poland.
- Laboratory of Recombinant Proteins Production, Faculty of Veterinary Medicine University of Agriculture in Krakow, 1C Redzina Street, 30-248 Krakow, Poland.
- Department of Animal Physiology and Endocrinology, University of Agriculture in Krakow, Mickiewicza 24/28 Street, 30-059 Krakow, Poland.
- Department of Diagnostics and Clinical Sciences, Faculty of Veterinary Medicine, University of Agriculture in Krakow, Mickiewicza 24/28 Street, 30-059 Kraków, Poland.
- Equine Vet Clinic EQUI-VET, Proszowice 55A, 32-100 Stogniowice, Poland.
Zitieren
APA
Semik-Gurgul, E., Ocłoń, E., Zubel-Łojek, J., Pędziwiatr, R., & Pawlina-Tyszko, K. (2026). Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells. Journal of Veterinary Internal Medicine. https://doi.org/10.1093/jvimsj/aalaf015
Vancouver
Semik-Gurgul E, Ocłoń E, Zubel-Łojek J, Pędziwiatr R, Pawlina-Tyszko K. Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells. Journal of Veterinary Internal Medicine. 2026. doi:10.1093/jvimsj/aalaf015
BibTeX
@article{SemikGurgul2026,
author = {Semik-Gurgul, Ewelina and Ocłoń, Ewa and Zubel-Łojek, Joanna and Pędziwiatr, Rafał and Pawlina-Tyszko, Klaudia},
title = {Cannabidiol-induced cellular and matrix-associated responses in primary equine sarcoid cells},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
doi = {10.1093/jvimsj/aalaf015}
}
EUVIMED